#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Perfusion-ventilation lung scintigraphy with hybrid imaging in patient with lung fibrosis – case report


Authors: Otto Lang
Published in: NuklMed 2022;11:69-72
Category: Casuistry

Overview

Introduction: Interstitial lung diseases (ILD, also fibrosing lung processes) are immunopatological processes in the lung interstitium, i.e. interalveolarly, in the alveoli and in peribonchium. They make difficult gas exchange in the alveolo-capillary membrane and cause respiratory insufficiency.

Case report: 59-y-old man was sent to our department to exclude pulmonary embolism. He was assessed by cardiologist due to lower extremities edema; it was concluded as a chronic venous insufficiency without heart role. Patient was followed for 19 years by pneumologist for ILD, type bronchiolitis obliterans. He suffers from chronical exertional dyspnea. There was neither pulmonary hypertension nor cor pulmonale on echocardiography.

There were quite homogenous perfusion and ventilation on lung scintigraphy, so we were able to exclude pulmonary embolism. We detected significant parenchymal changes with a mixed density and honeycomb character on a low dose nondiagnostic CT. So we can conclude the presence of interstitial damage in the lung without a significant changes of perfusion and ventilation, which explain clinical symptoms.

Conclusion: Hybrid lung scintigraphy in patients with interstitial lung diseases is able to explain the cause of dyspnea and simultaneously exclude pulmonary embolism by confirmation of parenchymal changes.

Keywords:

lung scintigraphy – SPECT/CT – lung fibrosis


Sources
  1. White ES, Thomas M, Stowasser S, et al. Challenges for Clinical Drug Development in Pulmonary Fibrosis. Front Pharmacol. 2022;31:13:823085 doi: 10.3389/fphar.2022.823085.
  2. Glass DS, Grossfeld D, Renna HA, et al. Idiopathic pulmonary fibrosis: Current and future treatment. Clin Respir J. 2022;16:84-96 doi: 10.1111/crj.13466.
  3. Národní radiologické standardy. Věstník MZ ČR č.2/2016. [online]. 2016. [cit. 2022-11-04]. Dostupné na https://www.mzcr.cz/nuklearni-medicina/
  4. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378:1949-1961
  5. Álvarez, D., Cárdenes, N., Sellarés, J, et al. IPF Lung Fibroblasts Have a Senescent Phenotype. Am. J. Physiol.- Lung Cell Mol. Physiol. 2017;313:L1164–L1173 doi:10.1152/ajplung.00220.2017
  6. van Manen MJG, Vermeer LC, Moor CC, et al. Clubbing in patients with fibrotic interstitial lung diseases. Respir Med. 2017;132:226-231
  7. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: From innocent targets to serial killers. Proc Am Thorac Soc. 2006;3:364-372
  8. Park J, Jung J, Yoon SH, et al. CT quantification of the heterogeneity of fibrosis boundaries in idiopathic pulmonary fibrosis. Eur Radiol. 2021;13:1-12
  9. Ebner L, Christodoulidis S, Stathopoulou T, et al. Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP). PLoS One. 2020;15:e0226084 doi: 10.1371/journal.pone.0226084.
  10. Tominaga J, Sakai F, Johkoh T, et al. Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: The effect of the integrated clinico-radiological assessment. Eur J Radiol. 2015;84:2640-2645 doi: 10.1016/j.ejrad.2015.08.016.
  11. Thieß HM, Bressem KK, Adams L, et al. Do submillisievert-chest CT protocols impact diagnostic quality in suspected COVID-19 patients? Acta Radiol Open. 2022;19:11:20584601211073864 doi: 10.1177/20584601211073864.
Labels
Nuclear medicine Radiodiagnostics Radiotherapy
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#